Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins

Missense mutations in two related genes, termed presenilin 1 (PS1) and presenilin 2 (PS2), cause dementia in a subset of early-onset familiar Alzheimer's disease (FAD) pedigrees. In a variety of experimental in vitro and in vivo settings, PAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrillogenic A beta 1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients. In this report, we demonstrate that transgenic animals that coexpress an PAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish PAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone. These results provide evidence for the view that one pathogenic mechanism by which PAD-linked mutant PS1 causes AD is to accelerate the rate of beta-amyloid deposition in brain.